ALDX
ALDX
NASDAQ · Biotechnology

Aldeyra Therapeutics Inc

$1.96
+0.13 (+7.10%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +2,103.1% upside
Low Target $31.72
Average Target $43.18
High Target $59.84
Current Price $1.96
Current
$1.96
Target
$43.18
$31.72 $43.18 avg $59.84
Scenario Analysis
Bear Case
$31.72
1,518.4%
Low target
Base Case
$43.18
+2,103.1%
Avg target
Bull Case
$59.84
+2,953.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.18
-68.3% from high
52-Week Low
$1.07
+83.2% from low
50-Day SMA
$1.68
+16.7% vs SMA
RSI (14)
47.8
Neutral
Target vs 52W High
$43.18
+599.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%